PAPSS2, a gene associated with androgen synthesis, is proposed by Ibeawuchi et al. to influence the progression of prostate cancer, where its gene deletion is closely linked to an increased risk of postoperative PSA recurrence, positioning PAPSS2 as a potential predictive biomarker for PSA recurrence32. This evidence concerns the gene PAPSS2 and Familial prostate cancer.